Objective: To examine the bidirectional relationship between weight change and obstructive sleep apnea (OSA) in the context of a behavioral weight loss intervention. Patients and Methods: Adults who were overweight or obese (N¼114) participated in a 12-month behavioral weight loss intervention from April 17, 2012, through February 9, 2015. The apneahypopnea index (AHI), a marker of the presence and severity of OSA, was assessed at baseline, 6 months, and 12 months. Linear mixed models evaluated the effect of weight change on the AHI and the effect of OSA (AHI !5) on subsequent weight loss. Secondary analyses evaluated the effect of OSA on intervention attendance, meeting daily calorie goals, and accelerometer-measured physical activity. Results: At baseline, 51.8% of the sample (n¼59) had OSA. Adults who achieved at least 5% weight loss had an AHI reduction that was 2.1AE0.9 (adjusted mean AE SE) events/h greater than those with less than 5% weight loss (P<.05). Adults with OSA lost a mean AE SE of 2.2%AE0.9% less weight during the subsequent 6-month interval compared with those without OSA (P¼.02). Those with OSA were less adherent to daily calorie goals (mean AE SE: 25.2%AE3.3% vs 34.8%AE3.4% of days; P¼.006) and had a smaller increase in daily activity (mean AE SE: 378.3AE353.7 vs 1060.1AE377.8 steps/d; P<.05) over 12 months than those without OSA. Conclusion: Behaviorally induced weight loss in overweight/obese adults was associated with significant AHI reduction. However, the presence of OSA was associated with blunted weight loss, potentially via reduced adherence to behaviors supporting weight loss. These results suggest that OSA screening before attempting weight loss may be helpful to identify who may benefit from additional behavioral counseling.
O bstructive sleep apnea (OSA) is a prevalent sleep disorder whose underlying pathogenesis is often driven by excess weight. [1] [2] [3] Multiple studies have found that weight loss is effective at reducing OSA severity. 4, 5 In particular, behavioral weight loss interventions, which typically incorporate dietary modification and physical activity to induce weight loss, reduce the apnea-hypopnea index (AHI) by 20% to 50%. 6 Accordingly, weight loss is a common first-line recommendation for overweight adults with OSA. 7 In contrast, less attention has been placed on the potential impact of underlying OSA on attempted weight loss. Evidence suggests that OSA can impede weight loss, [8] [9] [10] but these studies are limited by small sample sizes, 8, 10 and many did not consider adherence to behaviors supporting weight loss. 9, 10 Moreover, these samples included few women, who are more likely to engage in weight loss efforts than men 11 yet among whom OSA is less likely to be recognized. 12 The purpose of this study was to examine the bidirectional association between weight change and OSA in the context of a 12-month behavioral weight loss intervention. We examined the association between behaviorally induced weight loss and OSA severity and whether underlying OSA was associated with subsequent weight loss. Based on previous evidence, we hypothesized that OSA severity would be significantly reduced as a result of the lifestyle intervention. We also hypothesized that the presence of OSA would be associated with blunted weight loss and that adults with OSA would be less adherent with modifying caloric intake and physical activity compared with adults without OSA.
PATIENTS AND METHODS

Study Design and Sample
The present study was an ancillary component of the EMPOWER study. The primary aim of EMPOWER was to determine, using ecological momentary assessment methods, the triggers for lapses during intentional weight loss. 13 As a longitudinal descriptive study, all participants received a group-delivered behavioral weight loss intervention over 12 months. Additional details regarding participants and the intervention are described later herein and in the paper by Burke et al. 13 The University of Pittsburgh institutional review board approved the study protocol, and participants provided written informed consent before participating. The study was conducted from April 17, 2012, through February 9, 2015.
Adults 18 years and older with a body mass index (BMI; calculated as the weight in kilograms divided by the height in meters squared) of 27 to 44 who had not participated in a weight loss program in the previous 3 months were eligible. Exclusion criteria included the presence of medical conditions that could confound study findings (eg, diabetes), pregnancy, or other conditions that would prevent completion of the intervention. 13 All participants who were not being treated for OSA (eg, continuous positive airway pressure [CPAP] ) were eligible to participate in the ancillary study; see the Supplemental Figure (available online at http://www.mayoclinicproceedings.org) for data loss through the study. Thirty-seven of the 151 participants enrolled in EMPOWER (25%) were excluded from the present analyses, leaving 114 participants (75%); primary reasons for exclusion included study participation before the addition of OSA assessments (n¼18) and current OSA treatment (n¼9). In addition, 12 of the 114 participants (11%) withdrew before study completion. Compared with those who completed the study, participants who withdrew were younger (mean AE SD age: 44.1AE13.2 years vs 51.2AE9.9 years; P¼.03) and were less likely to be of white race (58.3% vs 85.3%; P¼.02); however, they did not differ on other factors, including baseline BMI or AHI.
All the participants received a standard behavioral weight loss intervention delivered in groups.
14 Key intervention components included provision of behavior change strategies such as daily dietary and weekly exercise goals along with self-monitoring of dietary intake, physical activity, and weight. 13 Daily caloric intake goals were based on initial body weight and sex. For those weighing less than 90.9 kg (ie, <200 lb), 1200 and 1500 kcal/d were prescribed for women and men, respectively; for participants weighing 90.9 kg or more, 1500 and 1800 kcal/d were prescribed for women and men, respectively. Participants were instructed to gradually increase their physical activity over the initial 6 weeks until they reached a goal of 150 min/wk. Sleep was not addressed as part of the intervention. Daily self-monitoring of dietary intake, physical activity, and weight were performed using a smartphone application (Lose It!; FitNow Inc). Twenty-four group sessions were offered: meetings occurred weekly for the initial 3 months, biweekly during months 4 through 6, and then monthly during the final 6 months.
Measures
Sociodemographic Data. Sociodemographic data (age, sex, marital status, race/ethnicity, smoking status) were collected using a selfadministered questionnaire.
Weight. Body weight was measured at baseline (BL), 6 months (6M), and 12 months (12M) by a digital scale (Tanita). Weight data at 6M and 12M are expressed as the percentage change from BL. Weight loss of at least 5% was considered clinically significant. 15 Obstructive Sleep Apnea. Obstructive sleep apnea was assessed using a limited-channel home sleep testing device (ApneaLink firmware version 05.02; ResMed) over single nights at BL, 6M, and 12M. This device records nasal pressure and pulse oximetry signals to derive summary measures of OSA. 16 Records were scored automatically using manufacturer-supplied software (version 9.30); an apnea was defined as an 80% or more decline in airflow for at least 10 seconds, and a hypopnea was defined as a 30% or greater decline in airflow for at least 10 seconds. The AHI was calculated as the sum of apneas and hypopneas divided by recording time in hours. Presence of OSA was defined as an AHI of at least 5. Two hours of valid recording time was required to include an OSA assessment in the analyses.
Intervention Behaviors. Three behaviors related to the intervention were assessed: group session attendance, adherence to daily calorie goals, and objectively monitored physical activity.
Group Session Attendance. We calculated the percentage of group sessions attended during the first 6 months (18 possible sessions) and the final 6 months (6 possible sessions).
Caloric Intake. Participants reported their caloric intake each day using a selfmonitoring application (Lose It!). Daily adherence to the prescribed caloric intake goal was calculated by dividing the calories consumed on a specific day by the daily caloric goal and then multiplying by 100. Participants were categorized as being adherent (reported consuming 85%-115% of the calorie goal) or nonadherent (reported consuming <85% or >115% of the calorie goal) each day; days without reported caloric intake were categorized as nonadherent. 17 We calculated the percentage of days the participant met their individual daily calorie goal as a summary measure of adherence, calculated separately for the first and final 6 months.
Physical Activity. Participants wore an accelerometer (GT3x; ActiGraph Corp) on their waist during waking hours for 7 days at BL, 6M, and 12M. Mean data from participants with at least 4 days of wear time of at least 10 h/d were included in the analyses. Daily durations of sedentary behavior and moderate-vigorous physical activity (MVPA) were established using standard cutoff points. 18 Steps per day and daily time spent sedentary and in MVPA were retained for analysis, using change scores at 6M and 12M by subtracting them from BL values.
Statistical Analyses
All participants with valid baseline data were included in the analyses. Data were first screened for any anomalies, which revealed several extreme AHI values at each time point. Although multiple strategies were considered to handle the extreme values (ie, winsorization, natural logarithm transformation), similar results were obtained regardless of approach; therefore, for ease of interpretation, untransformed data are reported. Change scores for AHI were normally distributed and were not transformed. Analyses evaluated the effects of the intervention on weight and the AHI, the association between changes in weight and the AHI, and whether OSA predicted subsequent weight change and intervention behaviors. All the analyses included covariates known to be associated with sleep or OSA: age (years), sex (male, female), race (white, black/other), marital status (never married, married/living with partner, widowed/divorced/ separated), and smoking status (current/former, never). Unless otherwise noted, sample descriptive statistics are summarized using mean AE SD or number (percentage), and outcomes are summarized using adjusted mean AE SE. All tests were 2-tailed, with statistical significance set at P<.05 using SAS version 9.4 (SAS Institute Inc).
Change in Weight and AHI Over Time. Using the marginal distribution of the observed data, linear mixed models were used to evaluate the trajectories of weight and AHI over time (BL, 6M, 12M). Models assumed a normal (Gaussian) error and identity link. Time point and covariates were included as fixed effects, with random effects for subjects; a random intercept model was fit, and compound symmetry was assumed across repeated assessments. Pairwise comparisons across time points were made using adjusted means. We used a generalized linear mixed model to evaluate whether OSA prevalence (AHI !5) differed across time points assuming a binomial error structure and logit link to the linear predictors.
Association of Weight Change With Change in OSA Severity. We used a linear mixed model, incorporating the BL-6M and BL-12M intervals and using the marginal distribution of available data, to assess whether at least 5% weight loss during a given interval was associated with AHI change. An interaction term evaluated whether the association differed according to the interval (BL-6M, BL-12M), and baseline AHI was included as a covariate.
Association of OSA Prevalence and Severity
With Weight Change and Intervention Behaviors. We evaluated whether the presence of at least mild OSA at the beginning of an interval (ie, AHI !5 at BL or 6M) was associated with weight change over the subsequent interval (BL-6M, 6M-12M) using a linear mixed model using the marginal distribution of available data. An interaction term evaluated whether the association differed according to the interval (BL-6M, 6M-12M), and BMI at the start of each interval was included as a covariate. We also repeated these analyses using continuous AHI values to examine whether OSA severity (regardless of mild OSA classification) was related to weight change.
We used linear mixed models to evaluate whether the presence of OSA at the beginning of an interval was associated with intervention-related behaviors (session attendance, adherence to daily calorie goals, physical activity [change in steps per day, change in sedentary time per day, change in MVPA per day]). An interaction term was included in the models to investigate whether the associations differed according to the interval (BL-6M, 6M-12M). For session attendance and adherence to daily calorie goals, BMI at the start of each interval was included as a covariate in each model; for activity outcomes, change in wear time and the respective activity parameter at the start of each interval were included as covariates.
RESULTS
Participant Characteristics
Baseline characteristics of the study sample (N¼114) are summarized in Association Between Weight Change and OSA The relationship between weight loss and AHI change is depicted in Figure 2 . Achievement of 5% or greater weight loss was associated with a mean AE SE of 2.1AE0.9 events/h greater AHI reduction relative to less than 5% weight loss (P<.05). The association between weight change and AHI change was consistent across time intervals (BL-6M, BL-12M; interaction P¼.72).
Association of OSA Status and Severity With Weight Change
The association between OSA status and subsequent weight change is depicted in Figure 3 . 
DISCUSSION
This study evaluated the bidirectional association between weight change and OSA in the context of a 12-month behavioral weight loss intervention. Overall, we found that weight loss reduced OSA severity but also that underlying OSA led to worse weight loss outcomes. In addition, those with OSA were less likely to adhere to daily calorie goals or to increase physical activity, despite similar attendance at intervention sessions. The behavioral weight loss intervention was associated with significant AHI reduction, which aligns with findings from most other behavioral weight loss interventions. 6, 19 Although the 12-month reduction in AHI was relatively small given the weight loss observeddapproximately 16% AHI reduction with 9% weight lossdthis may be at least partially due to the mild OSA severity at baseline. Despite this small magnitude of improvement, the odds of having OSA were 64% lower after the 12-month intervention. Thus, these results support the existing recommendation of weight loss for overweight adults with OSA, especially those with milderseverity OSA. 20 Although OSA is often implicated as a significant factor contributing to weight gain, 21 less inquiry has been made on the influence of OSA on weight loss. Whited et al 22 found that adults who were designated to be at high risk for OSA based on self-report lost 3% less weight after a 12-month dietary weight loss intervention than those screened as low risk. In a sample of 34 adults, Eraslan et al 10 observed that those with AHI values of 30 or greater were significantly less likely to achieve at least 3% weight loss after a 12-week lifestyle intervention compared with those with milder-severity OSA. Borel et al 8 reported that those with OSA at baseline (n¼28) had significantly smaller reductions in body weight, waist circumference, and fat mass after a 12-month lifestyle intervention compared with those without OSA (n¼49). More recently, in an analysis of more than 80,000 veterans enrolled in a 12-month weight loss program, Janney et al 9 found that those who were diagnosed as having sleep-disordered breathing lost approximately 0.4 kg less weight than those without this diagnosis. Finally, in a sample of 816 bariatric surgery patients, de Raaff et al 23 found that those with OSA at preoperative screening experienced less weight loss 6 and 12 months after surgery compared with those without OSA, although the strength of the relationship weakened considerably once confounders such as age and baseline BMI were considered. Because we found an approximately 2% difference in weight loss between those with and without OSA in a predominantly female sample with mild OSA, the present results are in agreement with previous behavioral weight loss interventions and indicate that even mild OSA may impair behavioral weight loss outcomes.
Compared with adults without OSA, those with OSA were less adherent to their daily calorie goals and had smaller improvements in daily physical activity despite similar attendance at intervention sessions. These results contrast with those of 2 previous studies that found no differences in self-reported caloric intake 8, 22 and self-reported 22 or pedometerassessed activity 8 between those with and without OSA. Although limited research is available, 21 the present finding of lower adherence to caloric intake goals is in agreement with research indicating that OSA is associated with greater fat consumption and greater overall energy intake. 24 Moreover, other studies have reported an inverse relationship between physical activity levels and OSA severity. 25, 26 The reduced adherence to behaviors supporting weight loss could be driven, at least in part, by the sleep disturbance brought on by underlying OSA. In adults without OSA, sleep restriction leads to increased energy intake and decreased physical activity. 27, 28 The present findings suggest that reduced adherence to these behaviors contributed to the lower weight loss observed in those with OSA in the present study. These results also raise the possibility that adults with OSA may need more extensive behavioral counseling to optimize adherence to behaviors supporting weight loss.
Although not measured in this study, the lower weight loss observed in those with OSA could also be due to metabolic dysregulation induced by OSA. Adults with OSA have altered glucose metabolism and impaired appetite regulation as a direct result of OSA or its associated sleep disturbance. 29, 30 Borel et al 8 found an inverse relationship between baseline OSA severity and improvement in glucose tolerance after the 12-month lifestyle intervention, alongside a smaller increase in plasma adiponectin. Future research should evaluate how these parameters respond to weight loss in adults with OSA.
The present results, as well as those of others, raise the question as to whether standard treatment of OSA (eg, CPAP) leads to greater weight loss in a behavioral weight loss intervention. However, the available evidence does not support this possibility. 31, 32 Most notably, in a sample of 181 adults with severe OSA, Chirinos et al 31 found that adding CPAP to a 6-month behavioral weight loss intervention did not result in greater weight loss compared with those who received only the weight loss intervention. In addition, outside of behavioral weight loss interventions, CPAP has been shown to lead to mild weight gain. 33 Despite these findings, it remains possible that OSA treatment may be a necessary precursor to minimize the barrier of poor sleep on behavior modification. 34, 35 Study limitations should be noted. The main limitation was the assessment of OSA. Although common in both clinical and research settings, use of a limited channel device to measure OSA parameters is less accurate than laboratory-based polysomnography. 36 Because respiratory events are expressed relative to recording duration rather than sleep duration, OSA parameters are often underestimated. 16 In addition, the lack of a control group with no lifestyle restrictions alongside the behavioral intervention was a study limitation for this analysis. There were also multiple strengths to this study. The sample, the largest to date to examine the effect of directly measured OSA on weight loss, was a significant strength. In particular, the high prevalence of females and mild-severity OSA are major strengths because women are more likely than men to attempt weight loss yet are less likely to be considered for OSA, 11, 12 and weight loss is often recommended for mild OSA. 37 Furthermore, we were able to assess multiple behaviors related to the weight loss intervention at multiple time points during the 12-month period, which allowed us to address potential behavioral factors that were related to the lower weight loss observed in those with OSA. Finally, although data loss occurred for a variety of other reasons (eg, device recording failure), low participant attrition was a study strength: 102 of the 114 participants (89.5%) included in these analyses completed the 12-month study.
CONCLUSION
Overall, we observed a bidirectional association between weight change and OSA in the context of a behavioral weight loss intervention. The blunted weight loss observed in those with OSA may be due to reduced adherence to behaviors supporting weight loss. This introduces a problematic cycle, wherein weight loss is recommended for mild and moderate OSA, but those with at least mild OSA are less likely to lose weight. These results suggest that OSA screening before initiation of weight loss efforts may be helpful to identify who may benefit from additional behavioral counseling. Future research should examine whether screening and treatment of OSA before initiating a behavioral weight loss intervention leads to better weight loss outcomes.
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